Literature DB >> 27602555

The SPRINT and the HOPE-3 Trial in the Context of Other Blood Pressure-Lowering Trials.

Salim Yusuf1, Eva Lonn1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27602555     DOI： 10.1001/jamacardio.2016.2169

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


× No keyword cloud information.
  5 in total

Review 1.  The Elusive Search for Optimal Blood Pressure Targets.

Authors:  Alan H Gradman
Journal:  Curr Hypertens Rep       Date:  2017-08       Impact factor: 5.369

2.  Hypertension highlights during 2016.

Authors:  Wilbert S Aronow
Journal:  Ann Transl Med       Date:  2017-10

Review 3.  Genomics of Cardiovascular Measures of Autonomic Tone.

Authors:  Martin I Sigurdsson; Nathan H Waldron; Andrey V Bortsov; Shad B Smith; William Maixner
Journal:  J Cardiovasc Pharmacol       Date:  2018-03       Impact factor: 3.105

4.  Role of Coronary Artery Calcium for Stratifying Cardiovascular Risk in Adults With Hypertension.

Authors:  S M Iftekhar Uddin; Mohammadhassan Mirbolouk; Sina Kianoush; Olusola A Orimoloye; Zeina Dardari; Seamus P Whelton; Michael D Miedema; Khurram Nasir; John A Rumberger; Leslee J Shaw; Daniel S Berman; Matthew J Budoff; John W McEvoy; Kunihiro Matsushita; Michael J Blaha; Garth Graham
Journal:  Hypertension       Date:  2019-05       Impact factor: 10.190

5.  Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular risk.

Authors:  Brian A Bergmark; Benjamin M Scirica; Ph Gabriel Steg; Christina L Fanola; Yared Gurmu; Ofri Mosenzon; Avivit Cahn; Itamar Raz; Deepak L Bhatt
Journal:  Eur Heart J       Date:  2018-06-21       Impact factor: 29.983
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.